the court addressed the issue of

whether the pharmacist’s failure to dispense the

FDA mandated PPI for progesterone was the

proximate cause of a congenital eye defect that

occurred. Because congenital defects, but not eye

deformities, were specified in the PPI, failure to

provide the PPI could not be proven to be the proximate cause. Therefore, judgment was in favor

of the pharmacy.